RxDoctor Payments Data

Kathy Robb, NP

Family · Bakersfield, CANPI 1639347248

Payments from drug & device makers

$21,660in general payments, 2019–2025

Across 963 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Daiichi Sankyo Inc.$2K
  • GSK$1K
  • AstraZeneca$1K
  • Seagen Inc.$898
  • Sobi, Inc$858
  • plus $14K from 54 others

What the payments were for

  • Food & beverage$20,53995%
  • Education$1,1215%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson88$1,878
Daiichi Sankyo Inc.88$1,637
GSK56$1,440
AstraZeneca(2 entities)49$1,197
Seagen Inc.34$898
Sobi, Inc37$858
Takeda Pharmaceuticals U.S.A., Inc.27$854
Astellas Pharma US Inc37$844
Pfizer39$767
Bristol Myers Squibb41$740
Amgen27$740
Exelixis Inc.38$720
Pharmacyclics LLC, An Abbvie Company26$595
Stemline Therapeutics Inc.17$518
Eisai Inc.24$514
Lilly USA, LLC22$506
E.r. Squibb & Sons, L.L.C.20$490
Novartis23$449
Sanofi21$420
Regeneron Healthcare Solutions, Inc.14$386
Genentech USA, Inc.19$378
Incyte Corporation20$357
Blueprint Medicines Corporation13$332
Puma Biotechnology, Inc.12$330
Merck14$306
Karyopharm Therapeutics Inc.11$237
Pharmaessentia USA Corporation8$211
Sun Pharmaceutical Industries Inc.10$210
Bayer10$180
Array Biopharma Inc17$172
AbbVie9$166
AMAG Pharmaceuticals, Inc.7$164
EMD Serono, Inc.7$151
Jazz Pharmaceuticals Inc.6$136
Genmab U.S., Inc.5$127
Gilead5$125
Viiv Healthcare Company1$125
Secura Bio, Inc.1$123
AVEO Pharmaceuticals, Inc.2$119
Caris MPI, Inc.3$100
Agios Pharmaceuticals, Inc.5$89
Aadi Bioscience, Inc.2$87
ADC Therapeutics America, Inc.4$86
Rigel Pharmaceuticals, Inc.4$84
Dendreon Pharmaceuticals LLC4$82
Blue Earth Diagnostics3$67
Deciphera Pharmaceuticals Inc.3$66
Apellis Pharmaceuticals, Inc.3$61
Geron Corporation2$60
Recordati_rare_diseases_inc.2$46
Boehringer Ingelheim2$41
Dova Pharmaceuticals2$38
Pharmacosmos Therapeutics Inc.2$37
Syndax Pharmaceuticals, Inc.2$33
Beigene USA, Inc.2$33
Cumberland Pharmaceuticals, Inc.1$30
Fennec Pharmaceuticals, Inc.1$25
Immunogen, Inc.1$23
Menarini Silicon Biosystems, Inc.1$19
Myriad Genetic Laboratories, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,660 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$194,280
Medicare patients
679
Services billed
2,172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl17$1,127
Hydroxyurea17$298
Prochlorperazine Maleate17$241
Letrozole14$181
Prednisone17$151

Paid to pharmacies, not to this prescriber.

Other family in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →